Researchers assessed the attainment of traditional cardiovascular risk factor therapeutic goals in patients with antiphospholipid syndrome vs those with rheumatoid arthritis and diabetes mellitus.
The 10-year risk for cardiovascular events in patients with rheumatoid arthritis (RA) was compared with that of patients with osteoarthritis (OA).
Authors of the systematic review and meta-analysis aimed to determine the all-cause and cause-specific mortality in psoriatic arthritis and ankylosing spondylitis, based on available literature.
Researchers evaluated the link between hydroxychloroquine use and corrected QT length in patients with SLE and RA without cardiovascular disease.
The objective of the study was to evaluate the trends for hospitalizations and inpatient mortality from acute myocardial infarction among patients with psoriatic arthritis.
Researchers compared the risk factors for unprovoked venous thromboembolism and atherosclerotic cardiovascular disease in patients with rheumatoid arthritis.
Researchers analyzed cardiovascular risk comorbidities among patients with rheumatoid arthritis, and the correlation between CV risk and the use of antirheumatic drugs.
Researchers aimed to study the associations between heart failure medications and certain systemic autoimmune rheumatic diseases.
